SERVImed presents an innovative line of viscosurgical solutions based on the newly developed and patented chemical entity Ribohyal, a new hyaluronic acid, colored and transparent, that allows for a better view of occupied spaces during surgeries and easier and safer removal of the viscoelastic.
SERVImed's ophthalmic viscosurgical portfolio is characterized by unique technical patents and formulations. These materials are a testament to SERVImed Industrial’s mission to bring innovation to the healthcare market.
Visco-surgical devices for intraocular use, based on the exclusive new Chemical Entity Ribohyal. They are used to create and maintain the anterior chamber space and protect endothelial cells during the procedures.
Viscorib 1.0 and 1.5 are used in ocular surgery as adjuvants to enhance contrast in anterior chamber surgery for improved visualization thanks to their coloration.
Viscorib 1.0 and 1.5 can be used in the following operations:
The NCE Ribohyal® (HAr) is synthesized by covalently binding riboflavin to hyaluronic acid's COOH and OH groups. Having less OH groups in the NCE makes it resistant to a fast hyaluronidase enzymatic degradation. This provides several advantages:
[email protected] Tel. +39 06 92595490 Fax +39 06 89360010 Certified email [email protected]
Raffaella Broccardo | [email protected]
Marco Maria Fedeli | [email protected], [email protected]
Edoardo Menna | [email protected] Tel. +39 337 113 84 07
Rosaria Tremamunno | [email protected] Tel. +39 348 991 4487
Andrea Napolitano | [email protected] Tel. +39 329 4757978
Silvia Assogna | [email protected]
Carmine Pontecorvo | [email protected]
Carmine Pontecorvo | [email protected]
Fabrizio Pieralisi | [email protected], [email protected]